Shionogi & Co., Ltd. (SGIOY) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free SGIOY Stock Alerts $11.40 -0.09 (-0.78%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 2:32 AM | americanbankingnews.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Shares Down 0.8% May 14, 2024 | msn.comShionogi & Co. reports FY resultsMay 13, 2024 | msn.comJapan's Shionogi says COVID treatment did not meet endpoint in late-stage trialMay 12, 2024 | markets.businessinsider.comWhat Wall Street expects from Shionogi's earningsMay 10, 2024 | bizjournals.comRegulators caused breakup of potential $750 million drug deal — now they've blessed company's latest moveMay 10, 2024 | finance.yahoo.comShionogi secures licence for Maze’s Pompe disease treatmentMay 8, 2024 | msn.comTeva hits a five-year high on schizophrenia trial win, Q1 beatApril 26, 2024 | marketbeat.comShort Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Declines By 42.1%Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 14,600 shares, a decline of 42.1% from the March 31st total of 25,200 shares. Based on an average daily trading volume, of 66,800 shares, the days-to-cover ratio is presently 0.2 days.March 18, 2024 | seekingalpha.comSGIOY Shionogi & Co., Ltd.March 12, 2024 | marketbeat.comShort Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Grows By 236.1%Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 12,100 shares, an increase of 236.1% from the February 14th total of 3,600 shares. Based on an average daily trading volume, of 107,500 shares, the days-to-cover ratio is currently 0.1 days.March 1, 2024 | marketbeat.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest UpdateShionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) saw a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 3,600 shares, a decline of 93.0% from the January 31st total of 51,700 shares. Based on an average daily volume of 89,000 shares, the short-interest ratio is presently 0.0 days.February 15, 2024 | wsj.comShionogi & Co. Ltd. ADRFebruary 1, 2024 | uk.investing.comShionogi & Co., Ltd. (4507)February 1, 2024 | marketbeat.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPSShionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.11). Shionogi & Co., Ltd. had a net margin of 42.96% and a return on equity of 18.36%. The firm had revenue of $719.72 million for the quarter.February 1, 2024 | markets.businessinsider.comHere's what to expect from Shionogi's earningsFebruary 1, 2024 | msn.comShionogi & Co. GAAP EPS of ¥435.74, revenue of ¥336.82BJanuary 13, 2024 | marketbeat.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Down 57.4% in DecemberShionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 4,600 shares, a drop of 57.4% from the December 15th total of 10,800 shares. Based on an average daily volume of 174,500 shares, the days-to-cover ratio is currently 0.0 days.December 18, 2023 | msn.comShionogi commences Phase III monovalent Covid-19 vaccine trialDecember 17, 2023 | msn.comShionogi & Co. - ADR (SGIOY) Price Target Increased by 14.91% to 16.05November 1, 2023 | benzinga.comApnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep DisordersSeptember 9, 2023 | finance.yahoo.comShionogi & Co., Ltd. (SGIOF)September 7, 2023 | finanznachrichten.deShionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious DiseaseAugust 1, 2023 | msn.comDaiichi COVID vaccine endorsed in Japan; Shionogi’s shot declinedJune 26, 2023 | finance.yahoo.comShionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.May 17, 2023 | msn.comShionogi starts clinical trial for its 2nd oral coronavirus drugApril 5, 2023 | marketwatch.comECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir TreatmentMarch 15, 2023 | marketbeat.comJefferies Financial Group Comments on Shionogi & Co., Ltd.'s FY2023 Earnings (OTCMKTS:SGIOY)Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Rating) - Analysts at Jefferies Financial Group decreased their FY2023 earnings per share (EPS) estimates for shares of Shionogi & Co., Ltd. in a report issued on Wednesday, March 8th. Jefferies Financial Group analyst S. Barker now anticipates that the cMarch 13, 2023 | marketbeat.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Expected to Post FY2023 Earnings of $1.06 Per ShareShionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Rating) - Equities researchers at Jefferies Financial Group reduced their FY2023 earnings per share (EPS) estimates for shares of Shionogi & Co., Ltd. in a research note issued on Wednesday, March 8th. Jefferies Financial Group analyst S. Barker now forecFebruary 22, 2023 | yahoo.comShionogi’s Antibiotic, FETCROJA® (cefiderocol), Is Now Available in the NetherlandsJanuary 17, 2023 | nz.finance.yahoo.comShionogi’s Innovative Antibiotic, FETCROJA® (cefiderocol), Is Now Available in NorwayDecember 26, 2022 | finance.yahoo.comShionogi & Co., Ltd. Unsponsored ADR (SGIOY) Upgraded to Buy: Here's WhyNovember 29, 2022 | yahoo.comKaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 DrugNovember 24, 2022 | news.yahoo.comShionogi seeks Japan approval for COVID-19 vaccineNovember 23, 2022 | yahoo.comLeading Japanese Pharmaceutical Company, Shionogi, Officially Opens Doors of Its New European Headquarters in AmsterdamNovember 22, 2022 | finance.yahoo.comJapan Approves First Homegrown Covid-19 Antiviral PillNovember 22, 2022 | news.yahoo.comJapan's Shionogi shares jump after report of COVID drug gaining efficacy approvalNovember 2, 2022 | benzinga.comOrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 DiabetesSeptember 29, 2022 | finance.yahoo.comShionogi & Co., Ltd. (SGIOY)September 28, 2022 | seekingalpha.comShionogi says COVID pill resolves Omicron symptoms faster, meets trial's goalSeptember 28, 2022 | usnews.comJapan's Shionogi Says COVID Pill Reaches Phase III MilestoneAugust 10, 2022 | msn.comShionogi confirms efficacy of oral COVID drug for Omicron subvariantAugust 3, 2022 | seekingalpha.comShionogi & Co. GAAP EPS of ¥115.13, revenue of ¥71.84BAugust 2, 2022 | investing.comShionogi & Co Ltd ADR (SGIOY)August 1, 2022 | benzinga.comShionogi Begins Phase 3 Study in Japan of Akili's Digital Treatment in Children with ADHDJuly 20, 2022 | marketwatch.comShionogi Shares Slump After Japan Panel Rejects Emergency Approval for Company's Covid-19 DrugJuly 20, 2022 | seekingalpha.comShionogi faces setback for COVID pill as Japan delays authorization againJune 1, 2022 | apnews.comShionogi Announces Strategic Re-Organization of U.S. Executive LeadershipApril 25, 2022 | seekingalpha.comShionogi says oral COVID-19 therapy rapidly cleared virus in mid-stage trialApril 24, 2022 | news.yahoo.comJapan's Shionogi says COVID-19 pill shows rapid clearance of virusApril 22, 2022 | seekingalpha.comPfizer set to add nearly $24 billion revenue with COVID-19 pill - Airfinity Get Shionogi & Co., Ltd. News Delivered to You Automatically Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. SGIOY Media Mentions By Week SGIOY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGIOY News Sentiment▼0.410.50▲Average Medical News Sentiment SGIOY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGIOY Articles This Week▼40▲SGIOY Articles Average Week Get Shionogi & Co., Ltd. News Delivered to You Automatically Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SDZNY News ERFSF News SSMXY News RCDTF News SKHHY News AMFPF News ACBFF News SBMFF News APNHY News HKMPF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SGIOY) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shionogi & Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
